Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cufryth M 15mg/50mg/2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Penryth Labs Private Limited

Salt Composition

Ambroxol (15mg) + Guaifenesin (50mg) + Terbutaline (2.5mg)

Overview Cufryth M 15mg/50mg/2.5mg Tablet

RespirAid M 15mg/50mg/2.5mg tablets alleviate coughs accompanied by phlegm. Its action thins and liquefies mucus within the nasal passages, trachea, and lungs, facilitating expulsion. Simultaneously, it relaxes and expands the airway muscles, easing respiration. RespirAid M 15mg/50mg/2.5mg tablets are administered with or without food, following your physician's prescribed dosage and duration. Dosage is individualized based on your condition and response. Continue treatment as directed; premature cessation may lead to symptom recurrence and worsening condition. Inform your doctor about all concurrent medications, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, abdominal pain, indigestion, headache, skin rash, palpitations, tremors, and tachycardia. Most are transient and self-limiting. Report any concerning side effects immediately. Drowsiness is a potential effect; avoid driving or tasks requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential increased sedation. Self-medication and recommending this medication to others are strongly discouraged. Adequate hydration is advised during treatment. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding, as well as any kidney or liver impairment, to ensure appropriate dosage.

Primary Ingredients of Cufryth M 15mg/50mg/2.5mg Tablet

The provided text is "undefined," which has no meaning and therefore cannot be rephrased.

Uses of Cufryth M 15mg/50mg/2.5mg Tablet

Productive cough

Major Benefits of Cufryth M 15mg/50mg/2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Cufryth M 15mg/50mg/2.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.

Common Side effects of Cufryth M 15mg/50mg/2.5mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Dizziness
  • Headache
  • Rash
  • Tremors
  • Increased heart rate
  • Indigestion
  • Bloating
  • Upper abdominal pain
  • Urticaria
  • Itching
  • Sweating
  • Changes in serum aminotransferase levels

How to use Cufryth M 15mg/50mg/2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Cufryth M 15mg/50mg/2.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, although consistent timing is recommended.

How Cufryth M 15mg/50mg/2.5mg Tablet works:

Each Cufryth M tablet (15mg/50mg/2.5mg) combines ambroxol, guaifenesin, and terbutaline to alleviate coughs accompanied by phlegm.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cufryth M 15mg/50mg/2.5mg Tablet lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant individuals should exercise caution with Cufryth M 15mg/50mg/2.5mg Tablets. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the risks versus benefits prior to any prescription. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Cufryth M 15mg/50mg/2.5mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Cufryth M 15mg/50mg/2.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Cufryth M 15mg/50mg/2.5mg Tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Cufryth M 15mg/50mg/2.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised, as data on its use in such patients is limited.

What if you forget to take Cufryth M 15mg/50mg/2.5mg Tablet :

Should you forget to take a Cufryth M 15mg/50mg/2.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cufryth M 15mg/50mg/2.5mg Tablet

LabelValue
Developing Habits No.
Treatment Category Breathing

FAQs on Cufryth M 15mg/50mg/2.5mg Tablet

Cufryth M 15mg/50mg/2.5mg Tablets treat coughs producing mucus (wet coughs).
Cufryth M 15mg/50mg/2.5mg Tablets are contraindicated in patients with allergies to any of its ingredients, heart disease, or peptic ulcers.
Increasing the dosage beyond what's recommended won't necessarily improve results; it could lead to serious side effects. If your symptoms persist or worsen despite taking the recommended dose, seek medical advice.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Cufryth M 15mg/50mg/2.5mg...
41
MRP 48
14% off